<SEC-DOCUMENT>0001140361-23-006351.txt : 20230213
<SEC-HEADER>0001140361-23-006351.hdr.sgml : 20230213
<ACCEPTANCE-DATETIME>20230213163431
ACCESSION NUMBER:		0001140361-23-006351
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230213
DATE AS OF CHANGE:		20230213

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		23619090

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sarissa Capital Management LP
		CENTRAL INDEX KEY:			0001577524
		IRS NUMBER:				900924432
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203-302-2330

	MAIL ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>ny20006859x18_dfan14a.htm
<DESCRIPTION>DFAN14A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div>
      <div style="text-align: center; font-weight: bold;">
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"><font style="font-size: 14pt;">UNITED STATES<font style="font-family: 'Times New Roman',Times,serif;"><br>
          </font>SECURITIES AND EXCHANGE COMMISSION</font><br>
        <font style="font-size: 12pt;">Washington, D.C. 20549</font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">SCHEDULE 14A</div>
      <div>&#160;</div>
      <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Proxy Statement Pursuant to Section&#160;14(a) of the<br>
          Securities Exchange Act of 1934</font> <br>
      </div>
      <div> <br>
      </div>
      <div>Filed by the Registrant&#8194;&#8201;&#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      <div>Filed by a party other than the Registrant&#8194;&#8201;&#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
      <div>&#160;</div>
      <div>Check the appropriate box:</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Preliminary Proxy Statement</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Definitive Proxy Statement</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#8194;&#8201;&#8201;Definitive Additional Materials</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Soliciting Material under &#167; 240.14a-12</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">Amarin Corporation plc</div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium; border-right: medium; border-top: medium none; margin: 0px auto; height: 2px; width: 100%; color: #000000;" align="center" noshade="noshade"></div>
      <div style="text-align: center;">&#160;(Name of Registrant as Specified In Its Charter)</div>
      <div>
        <div>&#160;</div>
      </div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Catapult Fund LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Hawkeye Fund LP</div>
      <div style="text-align: center; font-weight: bold;">ISP Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Offshore Master Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Master Fund II LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Athena Fund Ltd</div>
      <div style="text-align: center; font-weight: bold;">Atom Master Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Fund GP LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Fund GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Offshore Fund GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Management GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Management LP</div>
      <div style="text-align: center; font-weight: bold;">Alexander J. Denner, Ph.D.</div>
      <div style="text-align: center; font-weight: bold;">Patrice Bonfiglio</div>
      <div style="text-align: center; font-weight: bold;">Paul Cohen, M.D.<br>
        Mark DiPaolo<br>
        Keith L. Horn<br>
        Odysseas Kostas, M.D.</div>
      <div style="text-align: center; font-weight: bold;">Louis Sterling III<br>
        Diane E. Sullivan</div>
      <div style="text-align: center; font-weight: bold;">
        <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
      <div>
        <div style="text-align: center;">&#160;(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>
        <div>&#160;</div>
      </div>
      <div>Payment of Filing Fee (Check all boxes that apply):</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#8194;&#8201;&#8201;No fee required</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Fee paid previously with preliminary materials</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>This filing contains a press release issued on February 13, 2023 by Sarissa Capital.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SARISSA CAPITAL WARNS OF AMARIN&#8217;S EXPENSIVE ATTEMPTS TO SWITCH VOTES BY INUNDATING SHAREHOLDERS WITH WHITE PROXY CARDS</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">If You Already Voted a Proxy Card &#8220;FOR&#8221; the Sarissa Nominees and &#8220;FOR&#8221; the Removal of Chairman Per Wold-Olsen, There is NOTHING
      Else for You to Do</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">If You Have Any Questions or Have Not Yet Received a <font style="color: rgb(0, 32, 96);">BLUE </font>Proxy Card, Please Contact Sarissa&#8217;s Proxy Solicitor, D.F. King, by Calling (800) 331-7024</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">or Emailing AMRN@dfking.com</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">Greenwich, CT, February 13, 2023 &#8211; Sarissa Capital Management LP (&#8220;Sarissa&#8221;) today issued the following statement regarding Amarin Corporation plc
      (NASDAQ: AMRN):</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Amarin continues to waste precious shareholder capital in its self-serving attempts to keep shareholders out of the board room. Amarin has indicated
      that it will spend in excess of $7 MILLION to prevent Sarissa Capital, its largest shareholder, from obtaining representation on the board. This amount is a whopping ~6X more than what Sarissa intends to spend in this proxy contest. The most recent
      waste of money comes in the form of several expensive and duplicative mailings of white proxy cards to shareholders in an attempt to sway votes away from Sarissa.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Although Sarissa is outraged by the Amarin board squandering shareholder capital for its own entrenchment, we are not surprised as there has been a
      history of reckless spending and self-serving, unjust enrichment at Amarin. Notably, compensation has been insensitive to shareholder returns. In 2021, when the stock declined &gt;31% and shareholders lost &gt;$560 million in value,* the board gave
      CEO Karim Mikhail over $5.8 million in total compensation. Similarly, we doubt CEO Karim Mikhail&#8217;s 2022 compensation will fully reflect the poor performance under his watch last year. In late 2022, the year in which the stock declined &gt;64% and
      shareholders lost over $840 million in value,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8224;</sup> new directors were gifted $540,000 in stock and option grants on joining. Chairman Per Wold-Olsen alone was granted approximately $1 million of stock, options and cash in 2022.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8225;</sup></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Do not be misled by Amarin&#8217;s tactics to switch votes and do not be confused by the multiple mailings.&#160; If you already voted a proxy card &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Removal of Chairman Per
      Wold-Olsen, there is NOTHING else for you to do.&#160; <u>But any subsequent vote you make will revoke your prior vote.&#160; Only the last vote you submit will count.</u></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">We urge all shareholders to vote the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the removal of Chairman Per Wold-Olsen.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">If you have not received a <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card, you can vote the white proxy card but you must vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221;
      all proposals on the white proxy card to have the same effect as a vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; all proposals on the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font> proxy card.&#160; Voting <font style="font-weight: bold;">&#8220;FOR&#8221;</font> on the white proxy card has the same effect as
      voting &#8220;<font style="font-weight: bold;">FOR</font>&#8221; on the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font> proxy card.&#160;
      But if holders want to fully support Sarissa, they must make sure that all &#8220;<font style="font-weight: bold;">FOR</font>&#8221; boxes are marked on your proxy card before you submit it.&#160; <font style="font-weight: bold;">If you have any questions on how to vote, we recommend that you contact Sarissa&#8217;s proxy solicitor, D.F. King, by calling (800) 331-7024 or emailing AMRN@dfking.com</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Amarin is in dire need of change. Sarissa believes the current regime is wasting a uniquely valuable opportunity. Vascepa is a highly attractive asset
      that can not only meaningfully improve patients&#8217; lives by reducing cardiovascular events but also save significant money for health systems worldwide. The board, led by Chairman Wold-Olsen, has failed shareholders and takes no accountability for its
      failures. Sarissa urges shareholders to act now to support change so that the current leadership does not continue its misguided stewardship of shareholder capital.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">#FreeAmarin</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Visit our website at www.freeamarin.com<font style="color: rgb(5, 99, 193);"><u>&#160;</u></font>for helpful information about Sarissa and the need for change at Amarin.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the removal of Chairman Per Wold-Olsen.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, <font style="font-weight: bold;"><u>SUBMIT YOUR VOTE ON OR BEFORE TUESDAY, FEBRUARY 21, 2023</u></font>.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Shareholders should have received the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card. If you have not received your <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card or have any questions on how to vote, please contact:</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">D.F. King &amp; Co., Inc.</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">48 Wall Street</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">New York, New York 10005</div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Shareholders call toll-free:</font><font style="font-size: 10pt;"> (800) 331-7024</font></div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Banks and Brokers call:</font><font style="font-size: 10pt;"> (212) 269-5550</font></div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">By Email:</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman',Times,serif;">AMRN@dfking.com</font></font></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">* 2021 stock performance calculated from end of day December 31, 2020 &#8211; December 31, 2021. Source: Bloomberg</div>
    <div style="font-family: 'Times New Roman',Times,serif;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8224;</sup> 2022 stock performance calculated from end of day December 31, 2021 &#8211; December 30, 2022. Source: Bloomberg</div>
    <div style="font-family: 'Times New Roman',Times,serif;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8225;</sup> Calculated based on corporate filings</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Additional Information</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Sarissa Capital Management LP (&#8220;Sarissa Capital&#8221;), together with other participants, filed a definitive proxy statement and an accompanying blue proxy
      card with the SEC on January 31, 2023, in connection with the solicitation of shareholders of Amarin Corporation plc (the &#8220;Company&#8221;) at the general meeting of the Company for the election of Sarissa Capital&#8217;s slate of highly-qualified nominees (the
      &#8220;General Meeting&#8221;). Shareholders are advised to read the definitive proxy statement and other relevant documents related to the General Meeting as they contain important information.</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">The definitive proxy statement and other relevant documents are available at no charge on the SEC&#8217;s website at www.sec.gov and at www.freeamarin.com. The definitive proxy statement and other relevant documents are also available at no charge by
      directing a request to Sarissa Capital&#8217;s proxy solicitor, D.F. King &amp; Co., Inc., 48 Wall Street, New York, New York 10005 (Shareholders can call toll-free: (800) 331-7024).</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21b62dcac73d4adabdb70990f3dc770a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">Contact:</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman',Times,serif;">Jean Puong<br>
              Sarissa Capital Management LP<br>
              info@sarissacap.com</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div><br>
    </div>
    <div>&#160;</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
